David and Chamath discuss the recent IPOs in the synthetic biology industry and the potential for biology to become software. They believe that synthetic biology will revolutionize industry and improve sustainability, making it the great savior for our planet. While these companies may not have significant revenue yet, the capital markets are backing them, signaling a promising future for the industry.
